drugset / Trial / NCT07130383
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This is an open-label, multicenter Phase II study of MHB036C combined with MHB039A in patients with advanced Breast Cancer or other advanced malignant solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MHB036C and MHB039A combination therapy.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2029-08
- Completion
- 2031-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MHB036C | Other / unclassified | — | Intravenous |
| Subject | MHB039A | Unknown | — | Intravenous |